AT
SUPN icon

Arden Trust’s Supernus Pharmaceuticals SUPN Stock Holding History

Arden Trust’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-144
Closed -$3K – 694
2020
Q1 		$3K Buy
+144
New +$3.03K ﹤0.01% 669
2018
Q3 		– Sell
-4,062
Closed -$243K – 380
2018
Q2 		$243K Buy
+4,062
New +$210K 0.04% 321

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Arden Trust's SUPN Position: Q2 2020 in Review

Arden Trust sold out of Supernus Pharmaceuticals (SUPN) in Q2 2020, closing a stake of 144 shares — an estimated $3K sold.

Arden Trust first reported a position in SUPN in Q2 2018 and held it in 2 quarters. The position peaked at $243K in Q2 2018. 218 funds tracked by Wall St. Rank hold SUPN as of Q2 2020.

  • Arden Trust reported no remaining Supernus Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Arden Trust sold 144 Supernus Pharmaceuticals shares in Q2 2020, an estimated $3K.
  • Arden Trust first reported a position in Supernus Pharmaceuticals in Q2 2018 and held it in 2 quarters.
  • Arden Trust's Supernus Pharmaceuticals position peaked at $243K in Q2 2018.
  • 218 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2020.

Based on Arden Trust's 13F filing for Q2 2020, filed 9 Jul 2020.